Type‐2 asthma, which occurs in majority of children (>80%) and adults with asthma, is characterized by the presence of T2‐high biomarkers including elevated airway and peripheral eosinophils, elevated fractional exhaled nitric oxide (FeNO), and presence of allergen‐specific IgE [2, 3]. This evidence concerns the gene IGHE and asthma.